AOPEP and glioblastoma: Hence, APO synthesis is much less efficient in comparison to its intermediates A5 and C1 and the large-scale production of A5 and C1 is considered promising mainly due to the pharmacological potential demonstrated against GBM cells, by increasing cell death and impairing GSC formation.